Mereo BioPharma MREO
NASDAQ MREO
$0.29 0.00 (-1.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Total Non-Current Liabilities (2017 - 2026)

Updated

Mereo BioPharma (MREO) posted Total Non-Current Liabilities of $5.69 million for Q2 2026, down 28.0% from $7.91 million a year earlier and down 8.2% from the prior quarter.

Analysis

Mereo BioPharma (MREO) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Mereo BioPharma's Total Non-Current Liabilities came in at $4.34 million, down 70.3% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -45.7% (FY2020 to FY2025).
  • In prior years, Mereo BioPharma's Total Non-Current Liabilities was $14.6 million in FY2024 (-3.9%), $15.2 million in FY2023 (+745.2%), $1.8 million in FY2022 (-94.8%) and $34.88 million in FY2021 (-61.9%).
  • Quarterly Total Non-Current Liabilities has run from a low of $1.8 million in Q4 2022 to a high of $160.24 million in Q3 2024 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last seven quarters, with an average decline of 43.9% over the last seven quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2023, with growth of 745.2%; the weakest was Q3 2025, with a decline of 96.0%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $6.2 million (Q1 2026), $4.34 million (Q4 2025) and $6.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 102.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 106.45 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 33.91 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 35.10 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 97.04 Bn
10 Mereo BioPharma 46.19 Mn -103.72 Mn - 5.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.60 Mn
Mar 31, 2026 6.15 Mn
Dec 31, 2025 4.27 Mn
Sep 30, 2025 5.99 Mn
Jun 30, 2025 7.45 Mn
Mar 31, 2025 7.39 Mn
Dec 31, 2024 13.97 Mn
Sep 30, 2024 159.60 Mn
Jun 30, 2024 15.96 Mn
Mar 31, 2024 11.69 Mn
Dec 31, 2023 14.76 Mn
Jun 30, 2023 6.86 Mn
Dec 31, 2022 1.85 Mn
Jun 30, 2022 3.94 Mn
Dec 31, 2021 34.93 Mn
Jun 30, 2021 75.25 Mn
Dec 31, 2020 94.53 Mn
Jun 30, 2020 77.77 Mn
Dec 31, 2019 21.39 Mn
Jun 30, 2019 34.29 Mn
API Access

Mereo BioPharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MREO&period=max&api_key=YOUR_API_KEY